Market Research Report
Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast - 2027
|Published by||DelveInsight Business Research LLP||Product code||703428|
|Published||Content info||180 Pages
Delivery time: 1-2 business days
|Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast - 2027|
|Published: September 1, 2018||Content info: 180 Pages||
DelveInsight's "Phototherapies for Psoriasis - Market Insights, Epidemiology and Market Forecast - 2027" report provides an overview of the disease pathogenesis, Biomarkers, various diagnostic approaches and treatment algorithm including detailed chapters for marketed products and various marketed products patent details. The report also includes in depth research related to Phototherapies for Psoriasis for the 7MM including United States, EU-5 (Germany, France, Italy, Spain and UK) and Rest of the world for the study period undertaken from 2015-2027.
Study Period: 2016-2027
Phototherapies for Psoriasis Understanding and Treatment
The report provides the in depth analysis of the disease overview by providing details such as disease definition, symptoms, causes, pathogenesis, biomarkers, co-morbid conditions with psoriasis, different diagnostic approaches and guidelines of various regulatory bodies to treat and manage the psoriasis and treatment algorithm are also provided in the report.
Psoriasis is fundamentally an inflammatory skin condition with reactive abnormal epidermal differentiation and hyperproliferation which affects 2-3% of world's population. The pathophysiology of the disease includes mainly the activation and migration of T-cells to the dermis triggering the release of cytokines (tumor necrosis factor-alpha, TNF-alpha in particular) which lead to the inflammation and the rapid production of skin cells. A number of factors are responsible for triggering psoriasis. Among factors known to induce or worsen psoriasis are: mild localized trauma, such as scratching, piercings, tattoos, sunburns, chemical irritant, drugs including beta-blockers, lithium, anti-malarials, and non-steroidal anti-inflammatory drugs, HIV infection, and Stereptococcal pharyngitis. The climate in general and exposure to natural sun light in particular act as additional extrinsic factors with clinically important impacts on disease activity. Another factor of central importance is genetics.
Psoriasis Epidemiology Insights
This section provide the insights about the historical and current patient pool and forecasted trend segmented by 7 major markets. It enables understanding of the historical and forecasted epidemiological data for the prevalent cases of Psoriasis. Across 7MM, Psoriasis prevalent cases demonstrated an increasing trend and are forecasted to rise further in the coming years. Some of the key findings include:
This section focusses on the rate of uptake of the phototherapy for the treatment of psoriasis in the market during the study period from 2016-2027. A detailed historical market analysis has been conducted by DelveInsight for Phototherapies for Psoriasis, and currently, the market comprises of broad band ultraviolet, psoralen ultraviolet, low-level light/laser therapy, red light, blue light, and other different light and laser sources are available as first line to third line therapies depend up on the severity and localized part of psoriasis. Other research and development activities are set to add more combination therapies with phototherapy includes addition of topical agents, vitamin analogues and various systemic therapeutic candidates. This combinations and various laser sourced treatment for psoriasis reached the market and expand its global reach. DelveInsight projected current scenario and future scope for the treatment of psoriasis with phototherapy from 2016-2027.
Phototherapy for Psoriasis: 7 Major Market Analysis
This part of the Phototherapy for Psoriasis report encloses the detailed analysis of market size in US, EU5 countries for period of 2016-2027. United States had the highest market size of Phototherapy for Psoriasis in 2016, which accounts for approximately 55.71% of total 7MM market. The market was divide based on the phototherapy type and by end user application.
Epidemiology segmentation of Psoriasis
The report comprises of epidemiology section of total prevalent population by region wise, total diagnosed prevalent population, Severity specific diagnosed and treatable population by therapies and treatable population segmentation by the use of phototherapy across the 7MM regions.
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Reasons to buy: